Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)

NCT01340768 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

870

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Sulfonylurea
DRUG: Metformin

Sponsor

Merck Sharp & Dohme LLC